$Taro Pharmaceutical Industries (TARO.US)$Revenue has fluctu...

$Taro Pharmaceutical Industries(TARO.US)$Revenue has fluctuated and declined over the past 5 years, and operating profit has declined rapidly for 5 consecutive years. Net profit was once drastically lost in 2021, and in 2022 it only recovered to less than a quarter of 2020. Revenue increased 2.9% in the first two quarters of 2023, and operating profit fell sharply by 89.3%. Net profit increased 1.5 times due to the reduction of special expenses in 2022.